What is the priority document exchange program for patent applications?

The priority document exchange program is a system that allows participating patent offices to exchange priority documents electronically. According to MPEP 215.02(a): “Applicants may use the priority document exchange program to obtain a copy of a foreign application filed in a participating foreign intellectual property office.” This program simplifies the process of obtaining priority documents…

Read More

What is the significance of the ‘acting in a representative capacity’ requirement in patent applications?

What is the significance of the ‘acting in a representative capacity’ requirement in patent applications? The ‘acting in a representative capacity’ requirement is crucial in patent applications as it ensures that only authorized individuals can represent applicants or patent owners before the USPTO. According to MPEP 402.04, “Any paper presented to the United States Patent…

Read More

What is the process for submitting a biological sequence listing for a patent application filed on or after July 1, 2022?

For patent applications filed on or after July 1, 2022, the process for submitting biological sequence listings is as follows: Prepare a “Sequence Listing XML” as an XML file. Ensure the file complies with 37 CFR 1.831 – 1.834. Submit the file via the USPTO patent electronic filing system or on a read-only optical disc.…

Read More

How should trademarks be used in patent applications?

When using trademarks in patent applications: Capitalize each letter of the trademark Use the trademark symbol ® or TM as appropriate Accompany the trademark with generic terminology Respect the proprietary nature of the mark According to MPEP 608.01(v): “Although the use of marks having definite meanings is permissible in patent applications, the proprietary nature of…

Read More

Are USPTO employees allowed to communicate with suspended or excluded practitioners?

Generally, no. MPEP 105 states: “U.S. Patent and Trademark Office (USPTO) employees are forbidden to hold either oral or written communication with an attorney or agent who has been suspended or excluded from practice by the USPTO regarding an application.” This prohibition applies to all forms of communication about patent applications with suspended or excluded…

Read More